Age and drug therapy are key prognostic factors for first clinical fracture in patients with primary osteoporosis

Osteoporosis International

Volumn 18, Issue 8, 2007, Pages 1091-1100

  Gajic Veljanoski, O ^a,b   Sebaldt, R J ^c,d   Davis, A M ^b,e   Tritchler, D ^a   Tomlinson, G ^a,b   Petrie, A ^c   Adachi, J D ^c,d   Cheung, A M ^a,b,f  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d ST JOSEPH S HOSPITAL   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f NONE   (Canada)

Author keywords

Age; Drug therapy use; First clinical fracture; Primary osteoporosis; Prognostic factors

Indexed keywords

ALENDRONIC ACID; CALCITONIN; CALCIUM; CLODRONIC ACID; ESTROGEN; ETIDRONIC ACID; FLUORIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; RALOXIFENE; RISEDRONIC ACID; VITAMIN D;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FRAGILITY FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHYSICAL ACTIVITY; PRIMARY OSTEOPOROSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; EXERCISE; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 34347386101     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0340-1     Document Type: Article

References (61)

1. Melton LJ III, Chrischilles EA, Cooper C, Lane AW, Riggs BL (1992) Perspective. How many women have osteoporosis? J Bone Miner Res 7(9):1005-1010
2. Johnell O, Kanis JA, Oden A et al (2004) Mortality after osteoporotic fractures. Osteoporos Int 15(1):38-42
3. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359(9319):1761-1767
4. Lee SH, Dargent-Molina P, Breart G (2002) Risk factors for fractures of the proximal humerus: results from the EPIDOS prospective study. J Bone Miner Res 17(5):817-825
5. Cummings SR, Nevitt MC, Browner WS et al (1995) Risk factors for hip fracture in white women. N Engl J Med 332(12):767-773
6. Tromp AM, Smit JH, Deeg DJ et al (1998) Predictors for falls and fractures in the Longitudinal Aging Study Amsterdam. J Bone Miner Res 13(12):1932-1939
7. Papaioannou A, Joseph L, Ioannidis G et al (2005) Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 16(5):568-578
8. Siris ES, Miller PD, Barrett-Connor E et al (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286(22):2815-2822
9. Sebaldt RJ, Adachi JD (1996) Canadian Database of Osteoporosis and Osteopenia Patients (CANDOO). COACH Conference 21 Scientific Program Proceedings:36-39
10. Cheung AM, Feig DS, Kapral M et al (2004) Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian task force on preventive health care. CMAJ 170(11):1665-1667
11. Lewiecki EM, Watts NB, McCLung MR et al (2004) Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab 89(8):3651-3655
12. National Osteoporosis Foundation (2003) Physician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington (DC)
13. Laupacis A, Wells G, Richardson WS et al (1994) Users' guides to the medical literature V: how to use an article about prognosis. JAMA 272(3):234-237
14. Hudak PL, Cole DC, Haines AT (1996) Understanding prognosis to improve rehabilitation: the example of lateral elbow pain. Arch Phys Med Rehabil 77(6):586-593
15. Altman DG (2001) Systematic reviews of evaluations of prognostic variables. BMJ 323(7306):224-228
16. U.S. Preventive Services Task Force (2005) Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med 142(10):855-860
17. Guyatt GH, Cranney A, Griffith L et al (2002) Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures. Endocrinol Metab Clin North Am 31(3):659-679
18. Kleinbaum DG, Kupper LL, Muller KE et al (eds) (1998) Applied regression analysis and other multivariable methods. Duxbury Press, Pacific Grove, California
19. Austin PC, Tu JV (2004) Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol 57(11):1138-1146
20. Babyak MA (2004) What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 66(3):411-421
21. Allison PD (1995) Survival analysis using the SAS system: a practical guide. SAS Institute Inc, Cary, North Carolina
22. Harrell FE Jr (2001) Regression modeling strategies: with applications to linear models, logistical regression, and survival analysis. Springer-Verlag New York Inc, New York
23. Bull K, Spiegelhalter DJ (1997) Survival analysis in observational studies. Stat Med 16(9):1041-1074
24. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15(4):361-387
25. Venables W, Ripley B (eds) (1997) Modern applied statistics with S-plus. Springer-Verlag New York Inc., New York
26. Crawley M (2002) Statistical computing: an introduction to data analysis using S-Plus. Wiley, New York
27. Segal MR (1988) Regression trees for censored data. Biometrics 44(1):35-47
28. Fairclough D (2002) Missing data. In: Fairclough D (ed) Design and analysis of quality of life studies in clinical trials. Chapman & Hall, Boca Raton, Florida, pp 69-90
29. Little R, Rubin DB (2002) Statistical analysis with missing data. Wiley, Hoboken, New Jersey
30. Fairclough D (2002) Multiple imputation. In: Fairclough D (ed) Design and analysis of quality of life studies in clinical trials. Chapman & Hall, Boca Raton, Florida, pp 131-152
31. de Laet CE, Van Hout BA, Burger H et al (1997) Bone density and risk of hip fracture in men and women: cross sectional analysis. BMJ 315(7102):221-225
32. Burger H, de Laet CE, Weel AE et al (1999) Added value of bone mineral density in hip fracture risk scores. Bone 25(3):369-374
33. Siris ES, Chen YT, Abbott TA et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164(10):1108-1112
34. Pressman A, Forsyth B, Ettinger B et al (2001) Initiation of osteoporosis treatment after bone mineral density testing. Osteoporos Int 12(5):337-342
35. Brown JP, Josse RG (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(Suppl 10):S1-S34
36. Hamel ME, Sebaldt RJ, Siminoski K et al (2005) Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers. Osteoporos Int 16(2):208-215
37. Giangregorio L, Papaioannou A, Cranney A et al (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35(5):293-305
38. Levis S, Quandt SA, Thompson D et al (2002) Alendronate reduces the risk of multiple symptomatic fractures: results from the fracture intervention trial. J Am Geriatr Soc 50(3):409-415
39. Sackett DL, Haynes BR, Guyatt GH et al (eds) (1991) Clinical epidemiology: a basic science for clinical medicine. Little, Brown and Company, Boston
40. Meyer HE, Tverdal A, Falch JA (1995) Body height, body mass index, and fatal hip fractures: 16 years' follow-up of 674,000 Norwegian women and men. Epidemiology 6(3):299-305
41. Colon-Emeric CS, Pieper CF, Artz MB (2002) Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? development and validation of a clinical tool. Osteoporos Int 13(12):955-961
42. Ensrud KE, Lipschutz RC, Cauley JA et al (1997) Body size and hip fracture risk in older women: a prospective study. Am J Med 103(4):274-280
43. Van der Klift M, de Laet CE, McCloskey EV et al (2004) Risk factors for incident vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 19(7):1172-1180
44. De Laet C, Kanis JA, Oden A et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16(11):1330-1338
45. Snijder MB, van Dam RM, Visser M et al (2005) Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 90(7):4119-4123
46. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115(5):911-919
47. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423(6937):337-342
48. Weatherall M (2000) A meta-analysis of 25 hydroxyvitamin D in older people with fracture of the proximal femur. N Z Med J 113(1108):137-140
49. Bischoff-Ferrari HA, Dietrich T, Orav EJ et al (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 16(9):634-639
50. Gerdhem P, Ringsberg KA, Obrant KJ et al (2005) Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA study of elderly women. Osteoporos Int 16(11):1425-1431
51. Bischoff-Ferrari HA, Willett WC, Wong JB et al (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293(18):2257-2264
52. Hauner H (2005) Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 64(2):163-169
53. Zhao LJ, Liu YJ, Hamilton J et al (2006) Interventions decreasing obesity risk tend to be beneficial for decreasing risk to osteoporosis: a challenge to the current dogma. Osteoporos Int 17(Suppl 2):S161
54. Zhao L, Xiong D, Guo Y et al (2006) Genetic effects are associated with increased risk of both osteoporosis and obesity:a study of RANK gene. J Bone Miner Res 21(Suppl 1):S76
55. Nguyen TV, Center JR, Sambrook PN et al (2001) Risk factors for proximal humerus, forearm, and wrist fractures in elderly men and women: the Dubbo osteoporosis epidemiology study. Am J Epidemiol 153(6):587-595
56. Dargent-Molina P, Favier F, Grandjean H, Baudoin C et al (1996) Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet 348(9021):145-149
57. Frost HM (1997) On our age-related bone loss: insights from a new paradigm. J Bone Miner Res 12(10):1539-1546
58. Proctor DN, Melton LJ, Khosla S et al (2000) Relative influence of physical activity, muscle mass and strength on bone density. Osteoporos Int 11(11):944-952
59. Kanis JA, Johnell O, Oden A et al (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11(8):669-674
60. Sebaldt RJ, Kremer JM (2003) CANDOO and CANOAR, CORRONA and more: advancing therapeutics through layered-in clinical data collection and feedback at the point of care. J Rheumatol 30(11):2308-2311
61. Tierney WM, McDonald CJ (1991) Practice databases and their uses in clinical research. Stat Med 10(4):541-557